1-8 of 8
Claudia Paba Prada
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety of Elranatamab in Patients with Triple-Class Refractory Relapsed/Refractory Multiple Myeloma (RRMM) in Magnetismm-17, a North American Expanded Access Protocol

Free
Nizar J Bahlis, Suzanne Trudel, Christopher Maisel, Lisa X. Lee, Jorge Monge, Claudia Paba Prada, Sarah M. Larson, Guenther Koehne, Yogesh Jethava, Wei Dong Ma, Cristina De Nicolo, Isabel Perez-Cruz
Journal: Blood
Blood (2023) 142 (Supplement 1): 6737.
https://doi.org/10.1182/blood-2023-189700
Published: 2023
Journal Articles

How I treat the young patient with multiple myeloma

Free
Clinical Trials & Observations
Sara Gandolfi, Claudia Paba Prada, Paul G. Richardson
Journal: Blood
Blood (2018) 132 (11): 1114–1124.
https://doi.org/10.1182/blood-2017-05-693606
Published: 2018
Journal Articles

Next Generation Sequencing Identifies Smoldering Multiple Myeloma Patients with a High Risk of Disease Progression

Free
Mark Bustoros, Jihye Park, PhD, Karma Ziad Salem, MD, Chia-Jen Liu, MD PhD, Marzia Capelletti, PhD, Daisy Huynh, BS, MS, Yu-Tzu Tai, PhD, Tarek H Mouhieddine, MD, Samuel Freeman, Gavin Ha, PhD, Justin Rhoades, Sarah Reed, Gregory Gydush, Denisse Rotem, Adriana Perilla Glen, Patrick Henrick, BS, Aaron Caola, Bradley Rivotto, BS, Alexandra Savell, BS, Kimberly Noonan, NP, Kaitlen Reyes, NP, Antonio Sacco, Cody J Boehner, Houry Leblebjian, PharmD, David Liu, MD MPH, MS, Elizabeth A Morgan, MD, Aldo M. Roccaro, Claudia Paba-Prada, MD, Eliezer Van Allen, MD, Christopher Love, Viktor Adalsteinsson, PhD, Jacob Laubach, MD, Robert Schlossman, MD, Nikhil Munshi, MD, Paul G Richardson, MD, Kenneth C Anderson, MD, Shaji K Kumar, MD, Gad Getz, PhD, Irene M Ghobrial, MD, Salomon Manier, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 392.
https://doi.org/10.1182/blood.V130.Suppl_1.392.392
Published: 2017
Journal Articles

Impact of Bone Marrow Biopsy on Risk Stratification of Low-Risk IgG MGUS Patients

Free
Mark Bustoros, Eftathios Kastritis, Chia-Jen Liu, MD PhD, Nikolaos Kanellias, David Liu, MD MPH, MS, Maria Gavriatopoulou, Adriana Perilla Glen, Maria Roussou, Patrick Henrick, BS, Magdalini Migkou, Alexandra Savell, BS, Kimberly Noonan, NP, Kaitlen Reyes, NP, Bradley Rivotto, BS, Houry Leblebjian, PharmD, Claudia Paba-Prada, MD, Dimitrios C. Ziogas, Jacob Laubach, MD, Robert L. Schlossman, MD, Kenneth C Anderson, MD, Paul G Richardson, MD, Irene M Ghobrial, MD, Meletios A. Dimopoulos
Journal: Blood
Blood (2017) 130 (Supplement 1): 5397.
https://doi.org/10.1182/blood.V130.Suppl_1.5397.5397
Published: 2017
Journal Articles

First Report on Overall Survival (OS) and Improved Progression Free Survival (PFS) in a Completed Phase 2a Study of Melflufen in Advanced Relapsed Refractory Multiple Myeloma (RRMM)

Free
Paul G Richardson, MD, Sara Bringhen, MD, Peter M. Voorhees, MD, Torben Plesner, MD, Claudia Paba-Prada, MD, Ulf-Henrik Mellqvist, MD, Jeffrey A Zonder, MD, Brandi Reeves, MD, Antonio Palumbo, MD, Catriona Byrne, RN, Johan Harmenberg, MD PhD, Eva Nordstrom, MSc, MBA, Hanan Zubair, MSc, Jakob Lindberg, MD PhD, Pieter Sonneveld, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3150.
https://doi.org/10.1182/blood.V130.Suppl_1.3150.3150
Published: 2017
Journal Articles

Final Results of a Phase 2 Study of Modified Lenalidomide, Bortezomib, and Dexamethasone (RVD lite) in Transplant-Ineligible Multiple Myeloma

Free
Elizabeth O'Donnell, MD, Jacob Laubach, MD, Andrew J Yee, MD, Tianqi Chen, Carol Ann Huff, MD, Frank G. Basile, MD, Philip Wade, MD, Claudia Paba-Prada, MD, Irene M. Ghobrial, MD, Robert Schlossman, MD, Jill Burke, Harrington Cynthia, Kathleen Lively, Hannah Lyons, Nikhil Munshi, MD, Lorenzo Trippa, PhD, Kenneth C Anderson, MD, Paul G Richardson, MD, Noopur Raje, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3126.
https://doi.org/10.1182/blood.V130.Suppl_1.3126.3126
Published: 2017
Journal Articles

Determination of the MTD and Encouraging Results in an Ongoing Open-Label Phase 1/2a Study of the Safety and Efficacy of Melflufen and Dexamethasone in Combination for Patients with Relapsed and Relapsed-Refractory Multiple Myeloma (RRMM)

Free
Claudia Paba-Prada, MD, Antonio Palumbo, MD, Ulf-Henrik Mellqvist, MD PhD, Peter M Voorhees, MD, Torben Plesner, MD, Pieter Sonneveld, MD, Catriona Byrne, RN, Johan Harmenberg, MDPhD, Eva Nordstrom, MSc,MBA, Paul G. Richardson
Journal: Blood
Blood (2014) 124 (21): 2123.
https://doi.org/10.1182/blood.V124.21.2123.2123
Published: 2014
Journal Articles

Oprozomib and Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma: Initial Results from the Dose Escalation Portion of a Phase 1b/2, Multicenter, Open-Label Study

Free
Parameswaran N. Hari, MD, Kenneth H. Shain, MD PhD, Peter M. Voorhees, MD, Nashat Gabrail, MD, Muneer H. Abidi, MD, Jeffrey Zonder, MD, Ralph V. Boccia, MD, Paul G. Richardson, Linda L. Neuman, MD MBA, Sandra J. Dixon, MS, Claudia Paba Prada, MD
Journal: Blood
Blood (2014) 124 (21): 3453.
https://doi.org/10.1182/blood.V124.21.3453.3453
Published: 2014